Aisling Capital
PE / VC · New York · United States
Stages
Investment region
Industries
Profile
Aisling Capital is an investment firm based in New York, founded in 2000. It focuses on investing in companies that develop and commercialize innovative healthcare products, services, and technologies. The firm is staffed by a team of eight investment professionals who possess a combined 150+ years of experience in the healthcare industry. Aisling Capital distinguishes itself by leveraging its clinical, operational, and financial expertise to support the growth and success of its portfolio companies. The firm invests in a range of healthcare sectors including life sciences, targeting unmet medical needs through private and public companies. Investment structures employed by Aisling Capital include seed and venture financings for development-stage companies, as well as small-cap publicly traded equities, structured debt, royalty deals, and large-cap leveraged buyouts of profitable companies. Aisling Capital has raised over $1.8 billion in committed capital across five funds since its inception. Notable companies in Aisling Capital's portfolio include Quintiles, the largest provider of biopharmaceutical development services, Loxo, a company developing selective medicines for genomically defined cancers, and Zeltiq, known for their CoolSculpting® fat reduction technology. Other notable investments include Biohaven, T2 Biosystems, Harmony, and Aimmune, which are focused on innovative treatments and technologies in healthcare.
担当者 (2)
| Name | Title | 電話 | ||
|---|---|---|---|---|
| Operating Partner | — | — | — | |
| Partner | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.